Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam

被引:83
作者
Krauss, GL
Bergin, A
Kramer, RE
Cho, YW
Reich, SG
机构
[1] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA
[2] Colorado Neurol Inst, CNI Epilepsy Ctr, Englewood, CO USA
关键词
D O I
10.1212/WNL.56.3.411
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Posthypoxic and postencephalitic myoclonus is often poorly controlled with current treatments. The authors successfully treated three patients with posthypoxic and postencephalitic myoclonus by using levetiracetam, a new antiepileptic drug. Levetiracetam appears to be a promising agent for treating action myoclonus caused by hypoxic and encephalitic brain injury-the degree of functional improvement may depend on the severity of associated motor dysfunction.
引用
收藏
页码:411 / 412
页数:2
相关论文
共 5 条
[1]   Levetiracetam for partial seizures - Results of a double-blind, randomized clinical trial [J].
Cereghino, JJ ;
Biton, V ;
Abou-Khalil, B ;
Dreifuss, F ;
Gauer, LJ ;
Leppik, I .
NEUROLOGY, 2000, 55 (02) :236-242
[2]   The clinical spectrum of posthypoxic myoclonus [J].
Frucht, S ;
Fahn, S .
MOVEMENT DISORDERS, 2000, 15 :2-7
[3]  
Genton P, 2000, EPILEPTIC DISORD, V2, P99
[4]   Physiology of human posthypoxic myoclonus [J].
Hallett, M .
MOVEMENT DISORDERS, 2000, 15 :8-13
[5]   Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia [J].
Löscher, W ;
Richter, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 391 (03) :251-254